PUBLISHER: KBV Research | PRODUCT CODE: 1150560
PUBLISHER: KBV Research | PRODUCT CODE: 1150560
North America Transdermal Drug Delivery Systems Market Size, Share & Industry Trends Analysis Report By Application, By Type of Delivery System, By Country and Growth Forecast, 2022 - 2028
The North America Transdermal Drug Delivery Systems Market would witness market growth of 4.0% CAGR during the forecast period (2022-2028).
The term drug delivery system refers to a group of physicochemical techniques that can regulate the distribution and discharge of pharmacologically active chemicals into cells, tissues, and organs so that they can exert their effects as effectively as possible. DDS, therefore, addresses formulations that effectively administer the medicine to optimize therapeutic efficacy while minimizing any negative effects.
There are many different administration methods, including transdermal administration, oral administration, mucosal administration, lung inhalation, and intravenous injection, depending on the delivery route. The TDDS stands out among them as an appealing strategy. The distribution of numerous therapeutic agents has been greatly impacted by TDDS, particularly in the treatment of disorders of the cardiovascular (CVD) and central nervous systems, hormone therapy, and pain management.
Since TDDS avoids the digestive tract, there is no loss from first-pass metabolism, and medications can be administered without being hampered by pH, enzymes, or intestinal flora. The great persistence of this approach is also attributed to the ability of TDDS to manage medication release in accordance with usage limitations.
The trends of using transdermal drug delivery systems are increasing in North America because of factors including rising demand for non-invasive methods of drug delivery, the growing rate of chronic diseases, and high adoption of self-administration of medications. These factors accompanied by growing investments in R&D for the creation of novel drug delivery systems have made the US the largest market in North America for TDDS. In addition, TDDS is also popularizing in this nation as a result of the presence of numerous producers with strong product portfolios and an increase in product approvals for transdermal medication delivery systems.
The US market dominated the North America Transdermal Drug Delivery Systems Market by Country in 2021; thereby, achieving a market value of $20,370.9 million by 2028. The Canada market is experiencing a CAGR of 6.4% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 5.4% during (2022 - 2028).
Based on Application, the market is segmented into Analgesics, Hormone Replacement Therapies, Hypertension, Motion Sickness, Smoking Cessation and Others. Based on Type of Delivery System, the market is segmented into Passive and Active. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Viatris Inc., Bayer AG, Boehringer Ingelheim GmbH, Endo International plc, GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, Purdue Pharma L.P., Altaris and Hisamitsu Pharmaceutical Co. Inc.
Scope of the Study
Market Segments covered in the Report:
By Application
- Analgesics
- Hormone Replacement Therapies
- Hypertension
- Motion Sickness
- Smoking Cessation
- Others
By Type of Delivery System
- Passive
- Active
By Country
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- Viatris Inc.
- Bayer AG
- Boehringer Ingelheim GmbH
- Endo International plc
- GlaxoSmithKline plc
- Johnson & Johnson
- Novartis AG
- Purdue Pharma L.P.
- Altaris
- Hisamitsu Pharmaceutical Co. Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Transdermal Drug Delivery Systems Market, by Application
- 1.4.2 North America Transdermal Drug Delivery Systems Market, by Type of Delivery System
- 1.4.3 North America Transdermal Drug Delivery Systems Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition and Scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. North America Transdermal Drug Delivery Systems Market by Application
- 3.1 North America Analgesics Market by Country
- 3.2 North America Hormone Replacement Therapies Market by Country
- 3.3 North America Hypertension Market by Country
- 3.4 North America Motion Sickness Market by Country
- 3.5 North America Smoking Cessation Market by Country
- 3.6 North America Others Market by Country
Chapter 4. North America Transdermal Drug Delivery Systems Market by Type of Delivery System
- 4.1 North America Passive Market by Country
- 4.2 North America Active Market by Country
Chapter 5. North America Transdermal Drug Delivery Systems Market by Country
- 5.1 US Transdermal Drug Delivery Systems Market
- 5.1.1 US Transdermal Drug Delivery Systems Market by Application
- 5.1.2 US Transdermal Drug Delivery Systems Market by Type of Delivery System
- 5.2 Canada Transdermal Drug Delivery Systems Market
- 5.2.1 Canada Transdermal Drug Delivery Systems Market by Application
- 5.2.2 Canada Transdermal Drug Delivery Systems Market by Type of Delivery System
- 5.3 Mexico Transdermal Drug Delivery Systems Market
- 5.3.1 Mexico Transdermal Drug Delivery Systems Market by Application
- 5.3.2 Mexico Transdermal Drug Delivery Systems Market by Type of Delivery System
- 5.4 Rest of North America Transdermal Drug Delivery Systems Market
- 5.4.1 Rest of North America Transdermal Drug Delivery Systems Market by Application
- 5.4.2 Rest of North America Transdermal Drug Delivery Systems Market by Type of Delivery System
Chapter 6. Company Profiles
- 6.1 Viatris, Inc.
- 6.1.1 Company Overview
- 6.1.2 Financial Analysis
- 6.1.3 Segmental and Regional Analysis
- 6.1.4 Research & Development Expense
- 6.1.5 Recent strategies and developments:
- 6.1.5.1 Approval:
- 6.2 Purdue Pharma L.P.
- 6.2.1 Company Overview
- 6.3 Bayer AG
- 6.3.1 Company Overview
- 6.3.2 Financial Analysis
- 6.3.3 Segmental and Regional Analysis
- 6.3.4 Research & Development Expense
- 6.4 Novartis AG
- 6.4.1 Company Overview
- 6.4.2 Financial Analysis
- 6.4.3 Segmental and Regional Analysis
- 6.4.4 Research & Development Expense
- 6.5 Boehringer Ingelheim International Gmbh
- 6.5.1 Company Overview
- 6.5.2 Financial Analysis
- 6.5.3 Regional & Segmental Analysis
- 6.5.4 Research & Development Expenses
- 6.6 GlaxoSmithKline PLC
- 6.6.1 Company Overview
- 6.6.2 Financial Analysis
- 6.6.3 Segmental and Regional Analysis
- 6.6.4 Research & Development Expense
- 6.7 Johnson & Johnson
- 6.7.1 Company Overview
- 6.7.2 Financial Analysis
- 6.7.3 Segmental &Regional Analysis
- 6.7.4 Research & Development Expenses
- 6.8 Endo International PLC
- 6.8.1 Company Overview
- 6.8.2 Financial Analysis
- 6.8.3 Segmental and Regional Analysis
- 6.8.4 Research & Development Expense
- 6.9 Altaris Capital Partners, LLC
- 6.9.1 Company Overview
- 6.9.2 Recent strategies and developments:
- 6.9.2.1 Acquisition and Mergers:
- 6.10. Hisamitsu Pharmaceutical Co. Inc.
- 6.10.1 Company Overview
- 6.10.2 Financial Analysis
- 6.10.3 Recent strategies and developments:
- 6.10.3.1 Approval:
LIST OF TABLES
- TABLE 1 North America Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
- TABLE 2 North America Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
- TABLE 3 North America Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
- TABLE 4 North America Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
- TABLE 5 North America Analgesics Market by Country, 2018 - 2021, USD Million
- TABLE 6 North America Analgesics Market by Country, 2022 - 2028, USD Million
- TABLE 7 North America Hormone Replacement Therapies Market by Country, 2018 - 2021, USD Million
- TABLE 8 North America Hormone Replacement Therapies Market by Country, 2022 - 2028, USD Million
- TABLE 9 North America Hypertension Market by Country, 2018 - 2021, USD Million
- TABLE 10 North America Hypertension Market by Country, 2022 - 2028, USD Million
- TABLE 11 North America Motion Sickness Market by Country, 2018 - 2021, USD Million
- TABLE 12 North America Motion Sickness Market by Country, 2022 - 2028, USD Million
- TABLE 13 North America Smoking Cessation Market by Country, 2018 - 2021, USD Million
- TABLE 14 North America Smoking Cessation Market by Country, 2022 - 2028, USD Million
- TABLE 15 North America Others Market by Country, 2018 - 2021, USD Million
- TABLE 16 North America Others Market by Country, 2022 - 2028, USD Million
- TABLE 17 North America Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
- TABLE 18 North America Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
- TABLE 19 North America Passive Market by Country, 2018 - 2021, USD Million
- TABLE 20 North America Passive Market by Country, 2022 - 2028, USD Million
- TABLE 21 North America Active Market by Country, 2018 - 2021, USD Million
- TABLE 22 North America Active Market by Country, 2022 - 2028, USD Million
- TABLE 23 North America Transdermal Drug Delivery Systems Market by Country, 2018 - 2021, USD Million
- TABLE 24 North America Transdermal Drug Delivery Systems Market by Country, 2022 - 2028, USD Million
- TABLE 25 US Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
- TABLE 26 US Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
- TABLE 27 US Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
- TABLE 28 US Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
- TABLE 29 US Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
- TABLE 30 US Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
- TABLE 31 Canada Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
- TABLE 32 Canada Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
- TABLE 33 Canada Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
- TABLE 34 Canada Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
- TABLE 35 Canada Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
- TABLE 36 Canada Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
- TABLE 37 Mexico Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
- TABLE 38 Mexico Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
- TABLE 39 Mexico Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
- TABLE 40 Mexico Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
- TABLE 41 Mexico Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
- TABLE 42 Mexico Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
- TABLE 43 Rest of North America Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
- TABLE 44 Rest of North America Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
- TABLE 45 Rest of North America Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
- TABLE 46 Rest of North America Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
- TABLE 47 Rest of North America Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
- TABLE 48 Rest of North America Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
- TABLE 49 key information - Viatris, Inc.
- TABLE 50 Key Information - Purdue Pharma L.P.
- TABLE 51 Key Information - Bayer AG
- TABLE 52 Key Information - Novartis AG
- TABLE 53 Key Information - Boehringer Ingelheim International GmbH
- TABLE 54 Key Information - GlaxoSmithKline PLC
- TABLE 55 Key information - Johnson & Johnson
- TABLE 56 Key Information - Endo International PLC
- TABLE 57 Key Information - Altaris Capital Partners, LLC
- TABLE 58 Key Information - Hisamitsu Pharmaceutical Co. Inc.
List of Figures
- FIG 1 Methodology for the research
